Hemant Surgical Industries Ltd.

The trailing twelve month (TTM) PB ratio of Hemant Surgical Industries Ltd. is 2.03 as of June 18, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

Hemant Surgical Industries Ltd. reported an ROE of 25.06% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Hemant Surgical Industries Ltd., Promoter held 73.6%, the FII held 0.4%, DII held 1.1% and the public held 24.9% of the total shares.

You can easily buy shares of Hemant Surgical Industries Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Hemant Surgical Industries Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.